Following year-on-year success, Cambridge Healthtech Institute presents a four part conference focusing on advances in analytical characterization and bioassays for biopharmaceutical development, on comparability case studies for change implementation and on strategies for brining biosimilars through . The event includes a strong regulatory component and plenty of opportunity for discussions with the regulatory authorities and industry regulatory experts.
Who should attend: Attendees will include CEOs, VPs, Directors, Heads, Group Leaders and Scientists from Analytical Research & Development, Characterization, CMC and Quality Management, Biochemists, Formulation and Stability, Process Development, Operations, and Regulatory Affairs.
To submit a proposal for consideration, please click here.
The deadline for priority consideration is August 31, 2011.
All proposals are subject to review by the program Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biotech companies, regulators, and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For questions or suggestions about the meeting, please contact:
Nicole Lyscom
Conference Producer
Cambridge Healthtech Institute (CHI)
T: (+44)1483 826359
E: nlyscom@healthtech.com
For partnering and sponsorship information, please contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5483
E: jstroup@healthtech.com